XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Dec. 31, 2022
Jan. 01, 2022
Income Statement [Abstract]        
Net sales $ 123,708 $ 134,456 $ 260,971 $ 267,218
Cost of sales 114,788 124,648 241,672 247,272
Gross profit 8,920 9,808 19,299 19,946
Research, development and engineering expenses 2,287 2,498 4,583 4,947
Selling, general and administrative expenses 5,735 5,659 11,391 11,254
Gain on insurance proceeds, net of losses (2,710) 0 (3,644) 0
Total operating expenses 5,312 8,157 12,330 16,201
Operating income 3,608 1,651 6,969 3,745
Interest expense, net 2,507 1,095 4,394 2,087
Income before income taxes 1,101 556 2,575 1,658
Income tax provision (benefit) 134 (31) 456 256
Net income $ 967 $ 587 $ 2,119 $ 1,402
Net income per share - Basic (in USD per share) $ 0.09 $ 0.05 $ 0.20 $ 0.13
Weighted average shares outstanding — Basic (in shares) 10,762 10,762 10,762 10,762
Net income per share - Diluted (in USD per share) $ 0.09 $ 0.05 $ 0.20 $ 0.13
Weighted average shares outstanding — Diluted (in shares) 10,832 11,057 10,832 11,055